Life With GLP-1s
Clinical and cultural conversations around obesity have long revolved around BMI (and its credibility), harmful stereotypes, issues of equity and the multi-million dollar weight loss industry.
Read Resource
Latest Content
Roundup of most recently released content and assets.
-
-
How to Combat Muscle Loss While Taking GLP-1s
A side-effect of taking GLP-1s is a loss of muscle mass. Julie Mulcahy, PT, DPT, CAPP OB explores how to combat this with resistance exercises.
Read Article
-
New Research Shows Long-Term A1C Reduction and Sustained Weight Maintenance for Members in Omada Health’s Type 2 Diabetes Program
Omada Health, the virtual-first healthcare provider, published its 28th peer-reviewed study demonstrating the long-term outcomes of utilizing a behavior change program for members with type 2 diabetes
Read Article
-
Become an Omada Insider, subscribe to our monthly newsletter.
Sign me up -
The Science Behind Dieting, and Why it Doesn’t Work
Lisa McCormick, FNP-BC, RD, CDCES explores the science behind dieting and why it doesn't work. Find out more about sustainable weight loss!
Read Article
-
New Data Published by Omada Health Demonstrates the Impact of Coupling GLP-1s and Behavior Change Programming
Findings show that meaningfully engaged Omada members on GLP-1s achieved an average of 1.7 times greater weight loss, and inform a new collaboration with Evernorth's EncircleRx program.
Read Article
-
Webinar: Weight loss can’t cure obesity – So what can?
Obesity is now widely recognized as a lifelong chronic disease–but what’s behind that evolution? Join us to find out!
Read Article
-
NEBGH: 13th Annual Health and Wellness Benefits Conference
Leading Innovation at NEBGH 13th Annual Health and Wellness Benefits Conference
Read Article
-
HLTH 2024
Join Us at HLTH 2024 in Las Vegas!
Read Article
-
AHIP 2024 Consumer Experience & Digital Health Forum
Pioneering Transformation at AHIP 2024 Consumer Experience and Digital Health Forum
Read Article
-
AHIP 2024
Omada Health: Shining as a Gold Level Sponsor at AHIP 2024!
Read Article
-
Lockton People Solutions Conference
Charting New Frontiers at the Lockton People Solutions Conference 2024
Read Article
-
Thrive Summit 2024
A proud Gold Sponsor of the 2024 Thrive experience! Join our leaders, Tom Maraday and Kevin Masci on Thursday, April 11!
Read Article
-
Omada Health Expands Insights Lab to Advance Industry Learnings on Long-Term Weight Health
Building on more than a decade of insights and 28 peer-reviewed publications, Omada announces plans to develop more learnings focused on the long-term outcomes of GLP-1s on weight health
Read Article
-
Omada Health’s Guide to GLP-1s
Omada delivers GLP-1 FAQs focusing on weight loss quantity vs. quality with timely data and insights for employers, health plans and benefit consultants.
Read Article
-
How Essentia Health Achieves High Enrollment and Engagement in Its Virtual Diabetes Care Partnerships
Omada Health Customer Case Study: Learn how Essentia Health surpassed enrollment and engagement goals in its diabetes programs, and how they market virtual care solutions to their population.
Read Article
-
Omada Health Enhances GLP-1 Care Track to Support Customers Managing Medications and Integrates MSK Support
Omada Health Enhances GLP-1 Care Track to Support Customers Managing Medications and Integrates MSK Support.
Read Article
-
GLP-1 Demand Spotlights Existing Inequities in Obesity Care
Obesity is one of the clearest case studies of health disparities that exist in the U.S., having the biggest impact on Black and Hispanic adults, low-income populations, and people covered by Medicaid
Read Article
-
When Will GLP-1 Prices Drop?
GLP-1 agonist medications have had impressive initial outcomes. However, the long-term effects on a patient’s health beyond the trial timelines and on the costs to the healthcare system are uncertain.
Read Article
-
5 Reasons Diabetes Can't be Reversed
This Proof Points edition is based on the article Can Type 2 Diabetes be Reversed? Here’s What the Research Says.
Read Article
-
Long Term Results of a Digital Type 2 Diabetes Program
The purpose of this study is to examine the long-term impact of a digital diabetes self-management education and support (DSMES) program on A1C among adults with type 2 diabetes (T2DM).
Read Article
-
Loading More...
